Amneal Pharmaceuticals Inc
Amneal Pharmaceuticals's GHG Emissions Data Preview
In 2024, Amneal Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Amneal Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Amneal Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Amneal Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Amneal Pharmaceuticals's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Amneal Pharmaceuticals amounted to 142,900 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Amneal Pharmaceuticals increased by 0.14%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Amneal Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Amneal Pharmaceuticals's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Amneal Pharmaceuticals were 40,500 metric tons of CO₂ equivalent (tCO₂e). a
Has Amneal Pharmaceuticals reduced its Scope 1 emissions over time?
Since 2022, Amneal Pharmaceuticals's Scope 1 emissions have decreased by 3.34%, reflecting a declining long-term trend in Scope 1 emissions over time. a
Compared to the previous year (2023), Amneal Pharmaceuticals's Scope 1 emissions remained relatively stable, indicating that Amneal Pharmaceuticals's emissions have plateaued with no significant change in its operational footprint. a
What are Amneal Pharmaceuticals's Scope 2 emissions?
In 2024, Amneal Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 102,400 tCO₂e using the location-based method. a
Has Amneal Pharmaceuticals reduced its Scope 2 emissions over time?
Since 2022, Amneal Pharmaceuticals's Scope 2 greenhouse gas (GHG) emissions ( Location-Based) have remained relatively stable, indicating that Amneal Pharmaceuticals 's emissions have plateaued with no significant change in its energy consumption footprint. a
Compared to the previous year (2023), Amneal Pharmaceuticals's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Amneal Pharmaceuticals 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Amneal Pharmaceuticals use for Scope 2 reporting?
In 2024, Amneal Pharmaceuticals reported its Scope 2 emissions using the location-based method. a
Amneal Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
Insights into Amneal Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Amneal Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 40,500 tCO₂e and total revenues of USD 2,794 millions. This translates into an emissions intensity of 14.5 tCO₂e per millions USD. a
Amneal Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Amneal Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2024, Amneal Pharmaceuticals reported a Scope 1 emissions intensity of 14.5 tCO₂e per millions USD. Compared to the peer group median of 4.43 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Amneal Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2024, Amneal Pharmaceuticals ranked 17 out of 19 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Amneal Pharmaceuticals among the least efficient performers, with one of the highest emissions intensities in its sector. a